Results 201 to 210 of about 10,023 (257)

Neuromuscular Blocking Agents and Reversal Agents Usage, and Neuromuscular Blockade Monitoring in the Intensive Care Unit - Review Article. [PDF]

Int J Gen Med
Szewczyk M, Bieniecka A, Sobolewski K, Banasiak Ł, Grabarczyk Ł.   +4 more
europepmc   +1 more source

Use of prescribed analgesics before and after a standardised chiropractic care programme among patients with lumbar spinal stenosis: a nationwide cohort study. [PDF]

Chiropr Man Therap
Jensen RK, Bech M, Skovsgaard CV, Ryg J, Hartvigsen J, Johansson MS.   +5 more
europepmc   +1 more source

Therapeutic Challenges in Managing Triple-Negative Breast Cancer in a Patient With Central Core Disease. [PDF]

Cureus
Ibrahim F, Noor E, Khalil A, Sehbai U, Sehbai A.   +4 more
europepmc   +1 more source

Pain in multiple sclerosis: clinical phenotypes and therapeutic strategies - a narrative review. [PDF]

Pain Rep
Lang LS, Protopapa M, Bittner S, Birklein F.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Muscle Relaxant Action of MS-322, a New Centrally Acting Muscle Relaxant, in Rats

General Pharmacology: The Vascular System, 1998
1. The pharmacological properties of (R)-(+)-3-phenyl-5-¿2-(1-pyrrolidinylmethyl)-butyryl¿isoxazole hydrochloride (MS-322) were investigated and compared with those of other muscle relaxants. 2. MS-322 (3-12 mg/kg, IV) reduced spinal reflex potentials in acutely spinalized rats dose dependently.
T, Otsu, T, Nagao, H, Ono
openaire   +2 more sources

Cyclobenzaprine: A novel centrally acting skeletal muscle relaxant

Neuropharmacology, 1975
Abstract The muscle relaxant activity of cyclobenzaprine relative to chlorpromazine and diazepam in several animal models manifesting hypertonic skeletal muscle activity is described. In mice subjected to electrical and chemical induced tonic-extensor seizures, only cyclobenzaprine achieved a protective index greater than unity in all preparations ...
N N, Share, C S, McFarlane
openaire   +2 more sources

Centrally acting oral skeletal muscle relaxants

American Journal of Health-System Pharmacy, 1980
A critical examination of the literature on centrally acting, orally administered skeletal muscle relaxants (SMRs) is presented. The available comparative clinical studies are reviewed, and the pharmacology, metabolism and adverse effects of the oral SMRs are discussed briefly. The drugs covered are carisoprodol, chlorphenesin carbamate, chlorzoxazone,
openaire   +2 more sources

Pharmacological properties of NK433, a new centrally acting muscle relaxant

European Journal of Pharmacology, 1995
The pharmacological properties of NK433 ((-)-(R)-2-methyl-3-(1-pyrrolidinyl)-4'-trifluoromethylpropiophenone+ ++ monohydrochloride), a novel muscle relaxant, were investigated. NK433 inhibited intercollicular decerebrate rigidity (gamma-rigidity) and anemic decerebrate rigidity (alpha-rigidity) dose dependently.
K, Sakitama, Y, Ozawa, N, Aoto, K, Nakamura, M, Ishikawa   +4 more
openaire   +2 more sources